{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:26:24Z","timestamp":1791923184586,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-112-166"],"award-info":[{"award-number":["DMR-112-166"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tjog.2025.11.029","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:00:46Z","timestamp":1787670046000},"page":"966-973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Platinum sensitivity drives prognosis in endometriosis-associated ovarian carcinoma compared with high-grade serous ovarian carcinoma: Insights from a 10-year retrospective study"],"prefix":"10.1016","volume":"65","author":[{"given":"Yu-Wen","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Cheng","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Chung","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Chou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry","family":"Yin-Yi Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam-Fai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Shung","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2025.11.029_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tjog.2025.11.029_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.tjog.2025.11.029_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-05026-3","article-title":"Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival","volume":"6","author":"Kotnik","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.tjog.2025.11.029_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040952","article-title":"High-Grade serous ovarian cancer: basic Sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tjog.2025.11.029_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archsurg.1925.01120100007001","article-title":"Endometrial CARCINOMA of the ovary, arising in endometrial tissue in that organ","volume":"10","author":"Sampson","year":"1925","journal-title":"Arch Surg"},{"key":"10.1016\/j.tjog.2025.11.029_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(03)00047-2","article-title":"Prevalence of endometriosis in malignant epithelial ovary tumours","volume":"109","author":"Oral","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tjog.2025.11.029_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejogrb.2007.06.017","article-title":"Ovarian endometrioma--risks factors of ovarian cancer development","volume":"138","author":"Kobayashi","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tjog.2025.11.029_bib8","series-title":"Endometriosis-Associated ovarian carcinoma","author":"Pavaleanu","year":"2024"},{"key":"10.1016\/j.tjog.2025.11.029_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ygyno.2014.02.016","article-title":"Global distribution pattern of histological subtypes of epithelial ovarian cancer: a database analysis and systematic review","volume":"133","author":"Sung","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1158\/0008-5472.CAN-18-2726","article-title":"Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk","volume":"79","author":"Yang","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.tjog.2025.11.029_bib11","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/gyno.1996.0065","article-title":"Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease","volume":"60","author":"Goff","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1200\/JCO.1991.9.7.1138","article-title":"Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience","volume":"9","author":"Omura","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2005.12.038","article-title":"Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience","volume":"102","author":"Pectasides","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib15","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/cncr.24915","article-title":"Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy","volume":"116","author":"Bamias","year":"2010","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"key":"10.1016\/j.tjog.2025.11.029_bib16","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1002\/cam4.5453","article-title":"Patients with stage IA ovarian clear cell carcinoma do not require chemotherapy following surgery","volume":"12","author":"Shuqing","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.tjog.2025.11.029_bib17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ygyno.2014.01.012","article-title":"Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary","volume":"132","author":"Davis","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib18","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(17)30469-2","article-title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"18","author":"Pujade-Lauraine","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.annonc.2020.12.018","article-title":"Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial","volume":"32","author":"Wu","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/ijgc-2022-003704","article-title":"New therapies for clear cell ovarian carcinoma","volume":"33","author":"Stewart","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.tjog.2025.11.029_bib21","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S1470-2045(24)00437-6","article-title":"Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial","volume":"25","author":"Peng","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib22","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1200\/JCO.19.02059","article-title":"Randomized phase II trial of nivolumab versus nivolumab and ipilimumab for recurrent or persistent ovarian cancer: an NRG oncology study","volume":"38","author":"Zamarin","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib23","article-title":"Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: a case series","volume":"46","author":"Calo","year":"2023","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.tjog.2025.11.029_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.tjog.2025.11.029_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.100862","article-title":"8P NXP800 versus cisplatin in ARID1a-mutated ovarian clear cell carcinoma xenograft models","volume":"8","author":"Stewart","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.tjog.2025.11.029_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.100814","article-title":"34O ATR inhibitor alone (ceralasertib) or in combination with olaparib in gynaecological cancers with ARID1A loss or no loss: results from the ENGOT\/GYN1\/NCRI ATARI trial","volume":"8","author":"Banerjee","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.tjog.2025.11.029_bib27","article-title":"Ovarian cancer prognosis in women with endometriosis. A retrospective nationwide cohort study of 35,530 women","author":"Hermens","year":"2022","journal-title":"Endometriosis: not just a benign disease"},{"key":"10.1016\/j.tjog.2025.11.029_bib28","article-title":"Association between endometriosis and prognosis of ovarian cancer: an updated meta-analysis","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.tjog.2025.11.029_bib29","doi-asserted-by":"crossref","DOI":"10.31083\/j.ceog5004071","article-title":"Characteristics and prognosis of ovarian pure clear cell carcinoma: a retrospective experience of 136 patients","volume":"50","author":"Gao","year":"2023","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.tjog.2025.11.029_bib30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00404-018-4651-6","article-title":"Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?","volume":"297","author":"Sahin","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.tjog.2025.11.029_bib31","first-page":"1027","article-title":"Role of endometriosis as a prognostic factor for post-progression survival in ovarian clear cell carcinoma","volume":"7","author":"Ishibashi","year":"2017","journal-title":"Mol Clin Oncol"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455926002238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455926002238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:08:03Z","timestamp":1787861283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455926002238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1028455926002238"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2025.11.029","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platinum sensitivity drives prognosis in endometriosis-associated ovarian carcinoma compared with high-grade serous ovarian carcinoma: Insights from a 10-year retrospective study","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2025.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}